Probiotic bacterial strains and symbiotic composition containing the same intended for infant food
US-2019216864-A1 · Jul 18, 2019 · US
US10982184B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10982184-B2 |
| Application number | US-201214116996-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2012 |
| Priority date | May 9, 2011 |
| Publication date | Apr 20, 2021 |
| Grant date | Apr 20, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.
Opening claim text (preview).
The invention claimed is: 1. A method for preventive and/or curative treatment in a subject of hyperoxaluria, urolithiasis, kidney failure, cardiopathies, kidney stones, diverticulosis and diverticulitis, the method comprising administering to the subject a food composition or supplement product or medical device or pharmaceutical composition comprising a bacterial composition, said bacterial composition comprising the strain L. paracasei spp. paracasei LPC 09 DSM 24243. 2. The method according to claim 1 , wherein the composition further comprises at least one bacterial strain selected from the group consisting of the bacterial strain L. gasseri LGS 01 DSM 18299 and the bacterial strain L. gasseri LGS 02 DSM 18300. 3. The method according to claim 1 , wherein the composition further comprises bacterial strain L. acidophilus LA02 DSM 21717 and the bacterial strain L. acidophilus LA 07 DSM 24303. 4. The method according to claim 1 , wherein the composition further comprises fructo-oligosaccharides and inulin. 5. The method according to claim 1 , wherein said bacterial composition consists of L. paracasei spp. paracasei LPC 09 DSM 24243 , L. acidophilus LA02 DSM 21717 and L. acidophilus LA 07 DSM 24303. 6. The method according to claim 2 , wherein the composition further comprises fructo-oligosaccharides and inulin.
Lactobacillus · CPC title
Bacterial isolates · CPC title
Drugs for disorders of the urinary system · CPC title
Fructosans, e.g. inulin · CPC title
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.